Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer
Status:
Recruiting
Trial end date:
2029-04-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, single-arm, interventional study to explore the feasibility of
circulating tumor DNA (ctDNA)-MRD testing to guide postoperative adjuvant treatment
strategies in patients with stage II-III gastric cancer.
Phase:
N/A
Details
Lead Sponsor:
Qilu Hospital of Shandong University
Collaborators:
Jinan Central Hospital Shandong Provincial Hospital The Affiliated Hospital of Qingdao University Yantai Yuhuangding Hospital